Guardant Health, Inc. (GH) financial statements (2021 and earlier)

Company profile

Business Address 505 PENOBSCOT DR.
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments523419
Cash and cash equivalents143141
Short-term investments380278
Receivables4836
Inventory, net of allowances, customer advances and progress billings159
Inventory159
Other undisclosed current assets115
Total current assets:597469
Noncurrent Assets
Property, plant and equipment4431
Long-term investments and receivables26978
Long-term investments26978
Intangible assets, net (including goodwill)12 
Goodwill3 
Intangible assets, net (excluding goodwill)9 
Other noncurrent assets52
Other undisclosed noncurrent assets368
Total noncurrent assets:365118
TOTAL ASSETS:963587
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4218
Accounts payable1611
Accrued liabilities267
Debt 0
Deferred compensation liability1913
Other undisclosed current liabilities1216
Total current liabilities:7347
Noncurrent Liabilities
Long-term debt and lease obligation 0
Capital lease obligations0
Liabilities, other than long-term debt28
Deferred compensation liability, classified0 
Deferred rent credit 8
Other liabilities20
Other undisclosed noncurrent liabilities407
Total noncurrent liabilities:4216
Total liabilities:11562
Temporary equity, carrying amount5042
Stockholders' equity
Stockholders' equity attributable to parent, including:798483
Additional paid in capital1,150764
Accumulated other comprehensive income (loss)1(0)
Accumulated deficit(353)(281)
Other undisclosed stockholders' equity attributable to parent00
Total stockholders' equity:798483
TOTAL LIABILITIES AND EQUITY:963587

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues21491
Cost of revenue(66)(42)
Gross profit:14849
Operating expenses(230)(142)
Operating loss:(82)(93)
Nonoperating income1410
Investment income, nonoperating145
Other nonoperating income05
Interest and debt expense(1)(1)
Loss from continuing operations before income taxes:(70)(84)
Income tax expense (benefit)2(0)
Net loss:(68)(84)
Net loss attributable to noncontrolling interest(8)(1)
Net loss attributable to parent:(76)(85)
Preferred stock dividends and other adjustments(1)(1)
Other undisclosed net income available to common stockholders, basic11
Net loss available to common stockholders, diluted:(76)(85)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(68)(84)
Other comprehensive income10
Comprehensive loss:(67)(84)
Comprehensive loss, net of tax, attributable to noncontrolling interest(8)(1)
Comprehensive loss, net of tax, attributable to parent:(74)(85)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: